IVOG
Vanguard S&P Mid-Cap 400 Growth ETF
Vanguard S&P Mid-Cap 400 Growth ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to track the performance of the S&P Mid-Cap 400 Growth Index.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 1.6 B
ASSETS UNDER MGMT
10 bp
EXPENSES
Fund Basics
| Inception date | Sep 07, 2010 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Delayed |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| FLEXTRONICS INTL LTD | 2.9 % |
| CASEY'S GENERAL STORES INC | 1.8 % |
| TWILIO, INC. CLASS A | 1.7 % |
| TECHNIPFMC PLC | 1.6 % |
| NVENT ELECTRIC PLC | 1.5 % |
| CURTISS-WRIGHT CORP | 1.5 % |
| STERLING CONSTRUCTION CO | 1.4 % |
| MASTEC INC | 1.4 % |
| PURE STORAGE, INC. CLASS A | 1.4 % |
| UNITED THERAPEUTICS CORP | 1.3 % |
Constituent Breakdown
| Number of holdings | 247 |
| Herfindahl-Hirschman Index | 75 |
| Wgt avg mkt cap (mns) | $11,675 |
| Large cap (>$10bn) | 59.9% |
| Mid cap ($2-10bn) | 32.3% |
| Small cap (<$2bn) | 0.5% |
| Developed mkts. | 90.3% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 86.5 % |
 |
BRITAIN | 3.8 % |
 |
SINGAPORE | 2.9 % |
 |
CAYMAN ISLANDS | 1.2 % |
 |
IRELAND | 0.8 % |
 |
BERMUDA | 0.7 % |
Historical Performance
Standardized Performance (as of 04/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 12.2% | 31.1% | 12.4% | 15.2% | 5.9% | 10.3% | -- | 11.3% |
| Dividend Yield | 0.0% | 0.8% | 0.8% | 1.0% | 0.9% | 1.0% | -- | 0.9% |
| Total Returns | 12.2% | 31.9% | 13.2% | 16.1% | 6.8% | 11.3% | -- | 12.2% | Ann. Volatility | 20.4% | 17.5% | 20.3% | 18.8% | 20.6% | 20.6% | -- | 19.7% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.17 | 69% |
| MSCI EAFE | 0.84 | 49% |
| MSCI Emg Mkts | 0.65 | 47% |
Liquidity Measures
| Avg. volume (000) | 31 |
| ADV traded (mns) | $4 |
| Turnover | 0.3% |
| Avg. Bid/Ask (% of price) | 0.26% |
Technical Indicators
| 30d moving avg. (EMA) | $133.97 |
| Relative strength (RSI) | 61 |
| MACD/Signal | 2.39/2.10 |
| Bollinger Bands (Upper/Lower) | $140.26/$131.32 |
| Short interest (% of AUM) | 0.1% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. IVOG |
Expenses vs. IVOG |
ALTAR Score™ vs. IVOG |
|---|---|---|---|---|
| MDYG | State Street SPDR S&P 400 Mid Cap Growth ETF | 94.2% | +5 bp | 0.0% |
| IJK | iShares S&P Mid-Cap 400 Growth ETF | 94.1% | +7 bp | 0.0% |
| MDY | SPDR S&P Midcap 400 ETF Trust | 64.4% | +13 bp | +1.8% |
| XJH | iShares ESG Screened S&P Mid-Cap ETF | 62.8% | +2 bp | +1.9% |
| IVOO | Vanguard S&P Mid-Cap 400 ETF | 62.8% | -3 bp | +2.0% |
| SPMD | State Street SPDR Portfolio S&P 400 Mid Cap ETF | 62.4% | -7 bp | +2.0% |
| IJH | iShares Core S&P Mid-Cap ETF | 62.4% | -5 bp | +2.0% |
| QVMM | Invesco S&P MidCap 400 QVM Multi-factor ETF | 51.1% | +5 bp | +2.0% |
| SMOX | Horizon Small/Mid Cap Core Equity ETF | 46.8% | +65 bp | +1.2% |
| MIDE | Xtrackers S&P MidCap 400 ESG ETF | 44.2% | +5 bp | +2.8% |
Risk and Returns: IVOG vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 5/16/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
4.9%
ALTAR SCORE™
39th
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,207 funds in the US Equity category with an average
ALTAR Score™ of 5.4% and a standard deviation
of 2.1%. IVOG's ALTAR Score™ is approximately -0.3 standard
deviations above the category average. This places IVOG in the 39th percentile
among funds in the category.
Sell-Side Consensus
$150.69
PRICE TARGET
+9.7%
UPSIDE